MNX internals
| ||||||||||||||||||||||||||||
| Parent-child relations graph |
|
|||||||||||||||||||||||||||
| Identifier | Description |
|---|---|
CHEBI:58567 chebi:58567 CJDRUOGAGYHKKD-HEFSZTOGSA-O | ajmaline ajmalan-4-ium-17alpha,21alpha-diol ajmalinium |
kegg.compound:C06542 keggC:C06542 CJDRUOGAGYHKKD-UORGRDHFSA-N | Ajmaline |
kegg.drug:D00199 keggD:D00199 CJDRUOGAGYHKKD-HEFSZTOGSA-N | Ajmaline (JP18) Ajimalin (TN) |
| hmdb:HMDB0015495 CJDRUOGAGYHKKD-HEFSZTOGSA-N | Ajmaline (+)-Ajmaline (1R,9R,10S,12R,13S,14R,16S,18R)-13-ethyl-8-methyl-8,15-diazahexacyclo[14.2.1.0¹,⁹.0²,⁷.0¹⁰,¹⁵.0¹²,¹⁷]nonadeca-2,4,6-triene-14,18-diol (5AR,6S,8S,10S,11S,11as,12ar,13R)-5-methyl-5a,6,8,9,10,11,11a,12-octahydro-5H-6,10:11,12a-dimethanoindolo[3,2-b]quinolizine-8,13-diol Ajimalin Ajmalin ajmaline |
vmhM:ajmln vmhmetabolite:ajmln CJDRUOGAGYHKKD-HEFSZTOGSA-N | Ajmaline (1R,9R,10S,12R,13S,14R,16S,18R)-13-ethyl-8-methyl-8,15-diazahexacyclo[14.2.1.0¹,⁹.0²,⁷.0¹⁰,¹⁵.0¹²,¹⁷]nonadeca-2,4,6-triene-14,18-diol |
CHEBI:28462 chebi:28462 CJDRUOGAGYHKKD-HEFSZTOGSA-N | ajmaline (+)-Ajmaline (5aR,6S,8S,10S,11S,11aS,12aR,13R)-5-methyl-5a,6,8,9,10,11,11a,12-octahydro-5H-6,10:11,12a-dimethanoindolo[3,2-b]quinolizine-8,13-diol Ajmaline ajmalan-17alpha,21alpha-diol |
hmdb:HMDB15495 chebi:22275 chebi:2525 chebi:40717 keggC:M_C06542 keggD:M_D00199 vmhM:M_ajmln | secondary/obsolete/fantasy identifier |